SML3423
ARV-825
≥98% (HPLC)
同義詞:
(6S)-4-(4-chlorophenyl)-N-[4-[2-[2-[2-[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]ethoxy]phenyl]-2,3,9-trimethyl-6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide
登入查看組織和合約定價
全部照片(1)
About This Item
經驗公式(希爾表示法):
C46H47ClN8O9S
CAS號碼:
分子量::
923.43
MDL號碼:
分類程式碼代碼:
12352200
NACRES:
NA.77
推薦產品
品質等級
化驗
≥98% (HPLC)
形狀
powder
顏色
white to beige
溶解度
DMSO: 2 mg/mL, clear
儲存溫度
−20°C
SMILES 字串
ClC1=CC=C(C2=N[C@@H](CC(NC3=CC=C(C=C3)OCCOCCOCCOCCNC4=C(C5=CC=C4)C(N(C5=O)C6C(NC(CC6)=O)=O)=O)=O)C7=NN=C(C)N7C8=C2C(C)=C(C)S8)C=C1
InChI 密鑰
RWLOGRLTDKDANT-TYIYNAFKSA-N
生化/生理作用
ARV-825 is a hetero-bifunctional PROteolysis TArgeting Chimera (PROTAC) containing a BRD4 binding group (OTX-015) on one end, a linker arm, and a cereblon (CRBN) ubiquitin E3 ligase binding group (Pomalidomide) on the other end, resulting in BRD4 ubiquitylation and degradation by the proteasome. In Burkitt’s lymphoma cells, ARV-825 was found to cause prolonged BRD4 downregulation, reduce c-Myc levels, block cell proliferation, and induce apoptosis with improved results compared to BRD4 inihbitors such as JQ1 and OTX015. It showed similar results.
Hetero-bifunctional compound with a BRD4 binding group and a ubiquitin E3 ligase binding group, resulting in BRD4 ubiquitylation and degradation.
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 3
閃點(°F)
Not applicable
閃點(°C)
Not applicable
Maria Pia Abruzzese et al.
Journal of hematology & oncology, 9(1), 134-134 (2016-12-03)
Anti-cancer immune responses may contribute to the control of tumors after conventional chemotherapy, and different observations have indicated that chemotherapeutic agents can induce immune responses resulting in cancer cell death and immune-stimulatory side effects. Increasing experimental and clinical evidence highlight
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務